Developer docs
API playgroundTry for free, no card

Search company profiles

US BioTek Laboratories

Full company profile

uuid00093c9

Namestring
US BioTek Laboratories
Legal namestring
US BioTek Laboratories, LLC
Websiteurl
usbiotek.com
Company typeenum
Private
Founded yearint
1998
Descriptiontext

US BioTek Laboratories is a CLIA- and CAP-accredited specialty diagnostic laboratory founded in 1998 and headquartered in Shoreline, Washington (Seattle area). The company operates a multi-platform testing facility combining LC-MS/MS, ELISA, PCR, MALDI-TOF mass spectrometry, and metagenomic shotgun sequencing to deliver a broad functional medicine test menu spanning food sensitivity panels (96 to 240 analytes), organic acids profiles, GI microbiome assessments, hormone panels, nutritional markers, and environmental toxin/mycotoxin testing. Its proprietary VeriTek quality assurance process enforces duplicate testing and external accreditation accountability, which the company positions as a clinical reliability differentiator against competing functional laboratories.

The business serves exclusively licensed healthcare practitioners worldwide, primarily naturopathic physicians, integrative and functional medicine doctors, and holistic providers. Practitioners create accounts through a self-serve Clinician Portal, order free collection kits, collect specimens (fingerstick, dried blood spot, dried urine, stool), and return them via prepaid shipping for US/Canada or at shipper's cost internationally. US BioTek does not bill private insurance, Medicare, or Medicaid; revenue is collected via patient prepayment or practitioner professional accounts with credit on file. The company markets through content-driven channels (blog, webinars, sample reports, social media) targeting practitioner education and adoption.

Following the March 2024 acquisition of Realtime Laboratories and the March 2026 merger with Australian-based NutriPATH Pathology, US BioTek operates a trans-Pacific platform with NutriPATH retaining its brand presence in Australia. The company is portfolio-controlled by Pike Street Capital, a Seattle-based private equity firm whose inaugural $237M fund closed in December 2025. Founder Raymond Suen remains associated with the company alongside CEO Jack Frausing, and headcount remains in the 11-50 range despite the expanded geographic footprint.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersShoreline, United States
HQ citystring
Shoreline
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory testing, functional medicine diagnostics, food sensitivity panels, microbiome analysis services, environmental toxin testing
Industry4 codes
PRIMARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
SECONDARYHLAGADAN
Food, Feed & Nutraceutical Analytical Testing
SECONDARYHLAGADAE
Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)
SECONDARYAFALAAAA
Food Testing Laboratories (Microbiological, Chemical, Allergen)
Agriculture & Food Production/Food Safety, Testing & Certification/Food Testing Laboratories (Microbiological, Chemical, Allergen)
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
Product category
Clinical Diagnostic Laboratory Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Laboratory Testing Services
TypeOne Time License
Description

US BioTek generates revenue through laboratory diagnostic testing services ordered by licensed healthcare providers. Practitioners or patients prepay via credit card, or practitioners establish professional accounts with credit on file. The company does not bill insurance directly.

usbiotek.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

US BioTek Laboratories is a CLIA-accredited specialty clinical laboratory that performs functional and integrative medicine diagnostic testing on patient specimens submitted by licensed healthcare practitioners. Its menu spans food sensitivity panels (96–240 markers), organic acids profiling, GI microbiome analysis, hormone testing, environmental toxins, mycotoxins, heavy metals, and nutritional assessment, delivered via multi-platform analytical methods (LC-MS/MS, ELISA, PCR, MALDI-TOF, metagenomic shotgun sequencing) under the proprietary VeriTek quality process. Practitioners order kits, collect specimens, return them via prepaid shipping, and receive results through a secure Clinician Portal.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

US BioTek Laboratories offers a comprehensive portfolio of functional medicine diagnostic tests delivered through a multi-tier testing architecture. The core offering includes food sensitivity panels (ranging from 96 to 240 markers), organic acids testing (120+ markers), GI microbiome profiles (Basic/Standard/Advanced/GutIQ), and hormone profiles (EndoInsight, EndoInsight PLUS, SexInsight, CAR Profile). Specialty testing includes nutritional assessments (NutriStat Basic/Complete with 237-302 markers), environmental toxins panels (Heavy Metals, Environmental Toxins, Mycotoxins), and combined toxicology profiles (All-Tox, MOE-Tox Complete). Pediatric offerings include BabyBiome and PediatricBiome profiles. Environmental/building assessments include Mold Building Profile, Mycotoxin Building Profile, and Body & Building Profile. All testing is supported by the proprietary VeriTek quality assurance process with CLIA and CAP accreditation. The company recently merged with NutriPATH Pathology (March 2026) and acquired Realtime Laboratories (March 2024) to expand its global reach and testing portfolio.

Product and service29 records
1240 Food Sensitivity Panel
CategoryFood Sensitivity Testing
Description

Comprehensive ELISA-based food sensitivity test evaluating IgG, IgG4, IgA, and C3d antibody reactions across 240 food markers organized into dairy, fish/shellfish, grains, legumes, nuts, fruits, meat, poultry, egg, misc/herbs/spices, vegetables, and Candida categories; used by functional medicine practitioners for personalized dietary recommendations.

2198 Vegetarian Food Sensitivity Panel
CategoryFood Sensitivity Testing
Description

Specialized ELISA food sensitivity panel evaluating IgG, IgG4, IgA, and C3d antibody reactions across 198 vegetarian-specific food markers, designed for patients following vegetarian diets.

3144 Food Sensitivity Panel
CategoryFood Sensitivity Testing
Description

ELISA-based food sensitivity panel assessing 144 food antigens through IgG, IgG4, IgA, and C3d antibody analysis to support personalized dietary recommendations.

496 General Food Sensitivity Panel
CategoryFood Sensitivity Testing
Description

Essential ELISA-based food sensitivity test evaluating 96 key food analytes for IgG, IgG4, IgA, and C3d antibody responses to identify fundamental food sensitivities.

596 Vegetarian Food Sensitivity Panel
CategoryFood Sensitivity Testing
Description

Specialized ELISA-based vegetarian food sensitivity panel assessing 96 vegetarian analytes for IgG, IgG4, IgA, and C3d antibody responses.

6Organic Acids Profile
CategoryOrganic Acids Testing
Description

LC-MS/MS metabolic assessment measuring 120+ organic acids from a single liquid urine sample to evaluate nutrient absorption, vitamin deficiencies, mitochondrial energy production, gut microbiome balance, neurotransmitter metabolism, and detoxification capacity.

7NutriStat Complete
CategoryNutritional Testing
Description

Comprehensive nutritional assessment providing 302 nutritional markers across 37 testing categories, including metabolic/cardiovascular, vitamins, thyroid, amino acids, fatty acids, and minerals, using LC-MS/MS and automated biochemistry.

8NutriStat Basic
CategoryNutritional Testing
Description

Nutritional assessment offering 237 nutritional markers across 29 testing categories to provide insights into nutritional deficiencies and imbalances.

9GI Advanced Microbiome Profile
CategoryGI Microbiome Testing
Description

Comprehensive stool test with 133+ markers across 15 categories — including parasites, opportunistic bacteria, fungi/yeast, bacterial pathogens, viral pathogens, short chain fatty acids, and GI functional markers — using PCR, MALDI-TOF, and ELISA technologies.

10GI Standard Profile
CategoryGI Microbiome Testing
Description

Advanced GI profile employing cellular DNA technology with 127+ markers for sensitive, accurate, and reproducible gut microbiome assessment.

11GI Basic Profile
CategoryGI Microbiome Testing
Description

Entry-level GI microbiome profile measuring 110 markers across 8 GI testing categories using cellular DNA technology.

12GutIQ
CategoryGI Microbiome Testing
Description

Comprehensive stool analysis combining PCR and metagenomic shotgun sequencing with 200+ markers covering parasites, bacterial pathogens, H. pylori resistance genes, viral pathogens, mycology, and microbial diversity across 28,000+ microbial species.

13Oral Microbiome Profile
CategoryGI Microbiome Testing
Description

Quantitative PCR-based analysis of 21 oral microbiome markers — including bacteria and fungi species — to evaluate local dental issues and systemic health conditions linked to the oral microbiome.

14BabyBiome Profile
CategorySpecialty Microbiome Testing
Description

Comprehensive stool analysis designed for infants and toddlers using PCR and metagenomic sequencing, with age-appropriate reference ranges and personalized report commentary.

15PediatricBiome Profile
CategorySpecialty Microbiome Testing
Description

Comprehensive stool analysis for children and adolescents aged 3–17, combining PCR and metagenomic sequencing with age-specific reference ranges and personalized report commentary.

16EndoInsight PLUS Profile
CategoryHormone Testing
Description

Advanced dried urine hormone test providing 104 markers — including estrogens, progesterone, androgens, endocrine disruptors, glucocorticoids, free cortisol, free cortisone, free melatonin, organic acids, and a 6-point salivary Cortisol Awakening Response (CAR) assessment — measured via LC-MS/MS.

17EndoInsight Hormone Profile
CategoryHormone Testing
Description

Comprehensive dried urine endocrine profile with 93 markers, including hormone metabolites and endocrine disruptors, providing a 360-degree view of hormonal status to guide personalized treatment strategies.

18SexInsight Hormone Profile
CategoryHormone Testing
Description

Dried urine test providing focused insights into essential sex hormones with 43 markers, including primary hormones and symptom categories, to support personalized wellness strategies.

19Cortisol Awakening Response (CAR) Profile
CategoryHormone Testing
Description

Salivary test measuring cortisol levels at 6 points upon waking with 11 markers, providing detailed understanding of stress system activity and potential dysregulation.

20Environmental Toxins Panel
CategoryEnvironmental Toxins Testing
Description

Urine-based LC-MS/MS assessment measuring 49 select metabolites to evaluate toxic burden from long-term exposure to environmental chemicals and guide nutritional and detoxification interventions.

21Heavy Metals Panel
CategoryEnvironmental Toxins Testing
Description

Urine analysis testing 42 analytes for toxic elements — including lead, mercury, cadmium, and arsenic — to detect hidden exposure, evaluate toxic load, and support detoxification planning.

22MycoToxin Panel
CategoryEnvironmental Toxins Testing
Description

Urine test detecting 16 of the most common mycotoxins emitted by 300 varieties of molds — including aflatoxins and trichothecenes — using ELISA technology.

23All-Tox Profile
CategoryEnvironmental Toxins Testing
Description

Comprehensive combination profile bringing together 100+ toxins from Heavy Metals, Environmental Toxins, and Mycotoxins for a complete view of patient toxic burden, measured via LC-MS/MS and ELISA.

24MOE-Tox Complete Profile
CategoryEnvironmental Toxins Testing
Description

Combination profile bringing 100+ toxins from Heavy Metals, Environmental Toxins, and Mycotoxins together with 120+ Organic Acids for a complete view of toxic burden and mitochondrial function — 229 markers total.

25Mold Building Profile
CategoryEnvironmental/Building Testing
Description

Dust swab collection test for the presence of 15 toxigenic molds in homes, offices, or suspected living areas using PCR technology.

26Mycotoxin Building Profile
CategoryEnvironmental/Building Testing
Description

Spatial diagnostic test for 16 of the most toxic mycotoxins to humans present within living areas, aligned with the clinical Mycotoxin Profile for root cause analysis of patient exposures.

27Mold & Mycotoxin Building Profile
CategoryEnvironmental/Building Testing
Description

Dust swab test analyzing 15 toxigenic molds and 16 mycotoxins, providing insights into potential exposures and health risks from harmful substances in the built environment.

28Body & Building Profile
CategoryEnvironmental/Building Testing
Description

Combined body (urine) and building (dust swab) assessment covering 44 markers, including urinary mycotoxin metabolites, environmental molds, and environmental mycotoxins, for root-cause identification of patient exposures.

29COVID-19 Testing Services
CategoryInfectious Disease Testing
Description

CLIA-accredited COVID-19 laboratory testing services offered to U.S.-based providers during the pandemic, leveraging the company's existing clinical laboratory infrastructure.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-02
Description

Merger completed March 2026 combining US BioTek's immune reactivity, food sensitivity, and specialty biomarker testing with NutriPATH's functional pathology, nutritional assessment, and gut health diagnostics. NutriPATH continues operating under its established brand in Australia. Combined entity expands global footprint and offers an expanded portfolio of testing solutions to integrative and functional medicine practitioners worldwide.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-03-18
Description

Acquired by US BioTek in March 2024. The acquisition expanded US BioTek's diagnostic testing portfolio, adding Realtime Laboratories' capabilities to the company's existing test offerings.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Genova Diagnostics is one of the largest functional medicine specialty labs in the US, offering comparable panels including food sensitivity, GI stool profiles, hormone testing, and toxic/non-metal profiles. It is the most directly comparable competitor to US BioTek in serving naturopathic and integrative practitioners.

TypeDirect peer
Description

Doctor's Data is a specialty clinical laboratory focused on stool microbiology, toxic element exposure, and hormone testing for functional and integrative medicine practitioners. It directly overlaps with US BioTek's GI microbiome, heavy metals, and hormone test menu.

TypeDirect peer
Description

Mosaic Diagnostics provides organic acids testing (GPL-TOX, OAT), mold/mycotoxin panels, and comprehensive specialty biomarkers for the functional medicine community. Strong direct overlap with US BioTek's Organic Acids Profile, MycoToxin Panel, and Environmental Toxins offerings.

TypeDirect peer
Description

ZRT Laboratory is a specialty lab known for dried urine and saliva hormone testing (DUTCH-like profiles) plus vitamin D and cardio-metabolic markers. Comparable to US BioTek's EndoInsight dried urine hormone panels and CAR Profile for the integrative medicine channel.

TypeDirect peer
Description

Diagnos-Techs is a clinical laboratory offering saliva, stool, and blood-based specialty testing for functional and integrative medicine providers. Overlaps with US BioTek in hormone, GI, and adrenal testing for the same clinician base.

TypeDirect peer
Description

Meridian Valley Lab is a Seattle-area functional medicine reference laboratory offering hormone, food sensitivity, amino acid, and environmental testing. Geographic and product overlap with US BioTek, including dried urine hormone and specialty panels.

TypeDirect peer
Description

NutriPATH is an Australian functional pathology provider that merged with US BioTek in March 2026. Pre-merger it was a direct competitor in the Australian integrative medicine market and continues to operate as a retained brand post-merger.

TypeBroad incumbent
Description

Quest Diagnostics is the largest US clinical laboratory network, offering a broad menu including specialty endocrinology and infectious disease testing. While not focused on functional medicine, Quest's scale and payer relationships could pressure niche labs if it expands functional offerings.

TypeBroad incumbent
Description

Labcorp is a major US clinical laboratory offering routine and specialty diagnostics across endocrinology, infectious disease, and toxicology. It represents a broad incumbent that could compete on specialty testing and payer contracts if it deepens functional medicine capabilities.

TypeBroad incumbent
Description

Sonic Healthcare is a global medical diagnostics operator with reference lab businesses in Australia, Europe, and the US. Relevant given US BioTek's NutriPATH merger created Australian operations adjacent to Sonic's core geographies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

US BioTek Laboratories

Clinical Diagnostic Laboratory Servicesusbiotek.com

What US BioTek Laboratories does

US BioTek Laboratories is a CLIA- and CAP-accredited specialty diagnostic laboratory founded in 1998 and headquartered in Shoreline, Washington (Seattle area). The company operates a multi-platform testing facility combining LC-MS/MS, ELISA, PCR, MALDI-TOF mass spectrometry, and metagenomic shotgun sequencing to deliver a broad functional medicine test menu spanning food sensitivity panels (96 to 240 analytes), organic acids profiles, GI microbiome assessments, hormone panels, nutritional markers, and environmental toxin/mycotoxin testing. Its proprietary VeriTek quality assurance process enforces duplicate testing and external accreditation accountability, which the company positions as a clinical reliability differentiator against competing functional laboratories.

The business serves exclusively licensed healthcare practitioners worldwide, primarily naturopathic physicians, integrative and functional medicine doctors, and holistic providers. Practitioners create accounts through a self-serve Clinician Portal, order free collection kits, collect specimens (fingerstick, dried blood spot, dried urine, stool), and return them via prepaid shipping for US/Canada or at shipper's cost internationally. US BioTek does not bill private insurance, Medicare, or Medicaid; revenue is collected via patient prepayment or practitioner professional accounts with credit on file. The company markets through content-driven channels (blog, webinars, sample reports, social media) targeting practitioner education and adoption.

Following the March 2024 acquisition of Realtime Laboratories and the March 2026 merger with Australian-based NutriPATH Pathology, US BioTek operates a trans-Pacific platform with NutriPATH retaining its brand presence in Australia. The company is portfolio-controlled by Pike Street Capital, a Seattle-based private equity firm whose inaugural $237M fund closed in December 2025. Founder Raymond Suen remains associated with the company alongside CEO Jack Frausing, and headcount remains in the 11-50 range despite the expanded geographic footprint.

US BioTek Laboratories firmographics

Firmographics
Name
US BioTek Laboratories
Legal name
US BioTek Laboratories, LLC
Website
https://usbiotek.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

US BioTek Laboratories industry classification

Industry
Product category
Clinical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAFAMAB
Clinical Chemistry & Immunoassay Laboratories
SECONDARYHLAGADAN
Food, Feed & Nutraceutical Analytical Testing
SECONDARYHLAGADAE
Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility)
SECONDARYAFALAAAA
Food Testing Laboratories (Microbiological, Chemical, Allergen)
Agriculture & Food Production/Food Safety, Testing & Certification/Food Testing Laboratories (Microbiological, Chemical, Allergen)

Keywords

  • Clinical laboratory testing
  • Functional medicine diagnostics
  • Food sensitivity panels
  • Microbiome analysis services
  • Environmental toxin testing

Where US BioTek Laboratories is headquartered

Location

Headquarters

HQ city
Shoreline
HQ country
United States
HQ region
North America

Offices2 records

Markets served

US BioTek Laboratories business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Laboratory Testing Services: US BioTek generates revenue through laboratory diagnostic testing services ordered by licensed healthcare providers. Practitioners or patients prepay via credit card, or practitioners establish professional accounts with credit on file. The company does not bill insurance directly.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

US BioTek Laboratories product offering

Product offering

Core offering

US BioTek Laboratories is a CLIA-accredited specialty clinical laboratory that performs functional and integrative medicine diagnostic testing on patient specimens submitted by licensed healthcare practitioners. Its menu spans food sensitivity panels (96–240 markers), organic acids profiling, GI microbiome analysis, hormone testing, environmental toxins, mycotoxins, heavy metals, and nutritional assessment, delivered via multi-platform analytical methods (LC-MS/MS, ELISA, PCR, MALDI-TOF, metagenomic shotgun sequencing) under the proprietary VeriTek quality process. Practitioners order kits, collect specimens, return them via prepaid shipping, and receive results through a secure Clinician Portal.

Product overview

US BioTek Laboratories offers a comprehensive portfolio of functional medicine diagnostic tests delivered through a multi-tier testing architecture. The core offering includes food sensitivity panels (ranging from 96 to 240 markers), organic acids testing (120+ markers), GI microbiome profiles (Basic/Standard/Advanced/GutIQ), and hormone profiles (EndoInsight, EndoInsight PLUS, SexInsight, CAR Profile). Specialty testing includes nutritional assessments (NutriStat Basic/Complete with 237-302 markers), environmental toxins panels (Heavy Metals, Environmental Toxins, Mycotoxins), and combined toxicology profiles (All-Tox, MOE-Tox Complete). Pediatric offerings include BabyBiome and PediatricBiome profiles. Environmental/building assessments include Mold Building Profile, Mycotoxin Building Profile, and Body & Building Profile. All testing is supported by the proprietary VeriTek quality assurance process with CLIA and CAP accreditation. The company recently merged with NutriPATH Pathology (March 2026) and acquired Realtime Laboratories (March 2024) to expand its global reach and testing portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

  • 240 Food Sensitivity Panel Comprehensive ELISA-based food sensitivity test evaluating IgG, IgG4, IgA, and C3d antibody reactions across 240 food markers organized into dairy, fish/shellfish, grains, legumes, nuts, fruits, meat, poultry, egg, misc/herbs/spices, vegetables, and Candida categories; used by functional medicine practitioners for personalized dietary recommendations.
  • 198 Vegetarian Food Sensitivity Panel Specialized ELISA food sensitivity panel evaluating IgG, IgG4, IgA, and C3d antibody reactions across 198 vegetarian-specific food markers, designed for patients following vegetarian diets.
  • 144 Food Sensitivity Panel ELISA-based food sensitivity panel assessing 144 food antigens through IgG, IgG4, IgA, and C3d antibody analysis to support personalized dietary recommendations.
  • 96 General Food Sensitivity Panel Essential ELISA-based food sensitivity test evaluating 96 key food analytes for IgG, IgG4, IgA, and C3d antibody responses to identify fundamental food sensitivities.
  • 96 Vegetarian Food Sensitivity Panel Specialized ELISA-based vegetarian food sensitivity panel assessing 96 vegetarian analytes for IgG, IgG4, IgA, and C3d antibody responses.
  • Organic Acids Profile LC-MS/MS metabolic assessment measuring 120+ organic acids from a single liquid urine sample to evaluate nutrient absorption, vitamin deficiencies, mitochondrial energy production, gut microbiome balance, neurotransmitter metabolism, and detoxification capacity.
  • NutriStat Complete Comprehensive nutritional assessment providing 302 nutritional markers across 37 testing categories, including metabolic/cardiovascular, vitamins, thyroid, amino acids, fatty acids, and minerals, using LC-MS/MS and automated biochemistry.
  • NutriStat Basic Nutritional assessment offering 237 nutritional markers across 29 testing categories to provide insights into nutritional deficiencies and imbalances.
  • GI Advanced Microbiome Profile Comprehensive stool test with 133+ markers across 15 categories — including parasites, opportunistic bacteria, fungi/yeast, bacterial pathogens, viral pathogens, short chain fatty acids, and GI functional markers — using PCR, MALDI-TOF, and ELISA technologies.
  • GI Standard Profile Advanced GI profile employing cellular DNA technology with 127+ markers for sensitive, accurate, and reproducible gut microbiome assessment.
  • GI Basic Profile Entry-level GI microbiome profile measuring 110 markers across 8 GI testing categories using cellular DNA technology.
  • GutIQ Comprehensive stool analysis combining PCR and metagenomic shotgun sequencing with 200+ markers covering parasites, bacterial pathogens, H. pylori resistance genes, viral pathogens, mycology, and microbial diversity across 28,000+ microbial species.
  • Oral Microbiome Profile Quantitative PCR-based analysis of 21 oral microbiome markers — including bacteria and fungi species — to evaluate local dental issues and systemic health conditions linked to the oral microbiome.
  • BabyBiome Profile Comprehensive stool analysis designed for infants and toddlers using PCR and metagenomic sequencing, with age-appropriate reference ranges and personalized report commentary.
  • PediatricBiome Profile Comprehensive stool analysis for children and adolescents aged 3–17, combining PCR and metagenomic sequencing with age-specific reference ranges and personalized report commentary.
  • EndoInsight PLUS Profile Advanced dried urine hormone test providing 104 markers — including estrogens, progesterone, androgens, endocrine disruptors, glucocorticoids, free cortisol, free cortisone, free melatonin, organic acids, and a 6-point salivary Cortisol Awakening Response (CAR) assessment — measured via LC-MS/MS.
  • EndoInsight Hormone Profile Comprehensive dried urine endocrine profile with 93 markers, including hormone metabolites and endocrine disruptors, providing a 360-degree view of hormonal status to guide personalized treatment strategies.
  • SexInsight Hormone Profile Dried urine test providing focused insights into essential sex hormones with 43 markers, including primary hormones and symptom categories, to support personalized wellness strategies.
  • Cortisol Awakening Response (CAR) Profile Salivary test measuring cortisol levels at 6 points upon waking with 11 markers, providing detailed understanding of stress system activity and potential dysregulation.
  • Environmental Toxins Panel Urine-based LC-MS/MS assessment measuring 49 select metabolites to evaluate toxic burden from long-term exposure to environmental chemicals and guide nutritional and detoxification interventions.
  • Heavy Metals Panel Urine analysis testing 42 analytes for toxic elements — including lead, mercury, cadmium, and arsenic — to detect hidden exposure, evaluate toxic load, and support detoxification planning.
  • MycoToxin Panel Urine test detecting 16 of the most common mycotoxins emitted by 300 varieties of molds — including aflatoxins and trichothecenes — using ELISA technology.
  • All-Tox Profile Comprehensive combination profile bringing together 100+ toxins from Heavy Metals, Environmental Toxins, and Mycotoxins for a complete view of patient toxic burden, measured via LC-MS/MS and ELISA.
  • MOE-Tox Complete Profile Combination profile bringing 100+ toxins from Heavy Metals, Environmental Toxins, and Mycotoxins together with 120+ Organic Acids for a complete view of toxic burden and mitochondrial function — 229 markers total.
  • Mold Building Profile Dust swab collection test for the presence of 15 toxigenic molds in homes, offices, or suspected living areas using PCR technology.
  • Mycotoxin Building Profile Spatial diagnostic test for 16 of the most toxic mycotoxins to humans present within living areas, aligned with the clinical Mycotoxin Profile for root cause analysis of patient exposures.
  • Mold & Mycotoxin Building Profile Dust swab test analyzing 15 toxigenic molds and 16 mycotoxins, providing insights into potential exposures and health risks from harmful substances in the built environment.
  • Body & Building Profile Combined body (urine) and building (dust swab) assessment covering 44 markers, including urinary mycotoxin metabolites, environmental molds, and environmental mycotoxins, for root-cause identification of patient exposures.
  • COVID-19 Testing Services CLIA-accredited COVID-19 laboratory testing services offered to U.S.-based providers during the pandemic, leveraging the company's existing clinical laboratory infrastructure.

Companies that use US BioTek Laboratories

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles1 record

US BioTek Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

US BioTek Laboratories partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • NutriPATH PathologycoreStrategic or Co-development Partner · 2 March 2026Merger completed March 2026 combining US BioTek's immune reactivity, food sensitivity, and specialty biomarker testing with NutriPATH's functional pathology, nutritional assessment, and gut health diagnostics. NutriPATH continues operating under its established brand in Australia. Combined entity expands global footprint and offers an expanded portfolio of testing solutions to integrative and functional medicine practitioners worldwide.
  • Realtime LaboratoriesminorStrategic or Co-development Partner · 18 March 2024Acquired by US BioTek in March 2024. The acquisition expanded US BioTek's diagnostic testing portfolio, adding Realtime Laboratories' capabilities to the company's existing test offerings.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

US BioTek Laboratories competitors and assessment

Company assessment

Direct peers

  • Genova Diagnostics: Genova Diagnostics is one of the largest functional medicine specialty labs in the US, offering comparable panels including food sensitivity, GI stool profiles, hormone testing, and toxic/non-metal profiles. It is the most directly comparable competitor to US BioTek in serving naturopathic and integrative practitioners.
  • Doctor's Data: Doctor's Data is a specialty clinical laboratory focused on stool microbiology, toxic element exposure, and hormone testing for functional and integrative medicine practitioners. It directly overlaps with US BioTek's GI microbiome, heavy metals, and hormone test menu.
  • Mosaic Diagnostics (formerly Great Plains Laboratory): Mosaic Diagnostics provides organic acids testing (GPL-TOX, OAT), mold/mycotoxin panels, and comprehensive specialty biomarkers for the functional medicine community. Strong direct overlap with US BioTek's Organic Acids Profile, MycoToxin Panel, and Environmental Toxins offerings.
  • ZRT Laboratory: ZRT Laboratory is a specialty lab known for dried urine and saliva hormone testing (DUTCH-like profiles) plus vitamin D and cardio-metabolic markers. Comparable to US BioTek's EndoInsight dried urine hormone panels and CAR Profile for the integrative medicine channel.
  • Diagnos-Techs: Diagnos-Techs is a clinical laboratory offering saliva, stool, and blood-based specialty testing for functional and integrative medicine providers. Overlaps with US BioTek in hormone, GI, and adrenal testing for the same clinician base.
  • Meridian Valley Lab: Meridian Valley Lab is a Seattle-area functional medicine reference laboratory offering hormone, food sensitivity, amino acid, and environmental testing. Geographic and product overlap with US BioTek, including dried urine hormone and specialty panels.
  • NutriPATH Pathology: NutriPATH is an Australian functional pathology provider that merged with US BioTek in March 2026. Pre-merger it was a direct competitor in the Australian integrative medicine market and continues to operate as a retained brand post-merger.

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is the largest US clinical laboratory network, offering a broad menu including specialty endocrinology and infectious disease testing. While not focused on functional medicine, Quest's scale and payer relationships could pressure niche labs if it expands functional offerings.
  • Labcorp: Labcorp is a major US clinical laboratory offering routine and specialty diagnostics across endocrinology, infectious disease, and toxicology. It represents a broad incumbent that could compete on specialty testing and payer contracts if it deepens functional medicine capabilities.
  • Sonic Healthcare: Sonic Healthcare is a global medical diagnostics operator with reference lab businesses in Australia, Europe, and the US. Relevant given US BioTek's NutriPATH merger created Australian operations adjacent to Sonic's core geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

US BioTek Laboratories social profiles

Digital presence

US BioTek Laboratories compliance and trust

Trust signal

Compliance2 records

US BioTek Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

US BioTek Laboratories leadership team

Management profile

Number of profiles

Profiles2 records

US BioTek Laboratories subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

US BioTek Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

US BioTek Laboratories M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about US BioTek Laboratories

What does US BioTek Laboratories do?

US BioTek Laboratories is a CLIA-accredited specialty clinical laboratory that performs functional and integrative medicine diagnostic testing on patient specimens submitted by licensed healthcare practitioners. Its menu spans food sensitivity panels (96–240 markers), organic acids profiling, GI microbiome analysis, hormone testing, environmental toxins, mycotoxins, heavy metals, and nutritional assessment, delivered via multi-platform analytical methods (LC-MS/MS, ELISA, PCR, MALDI-TOF, metagenomic shotgun sequencing) under the proprietary VeriTek quality process. Practitioners order kits, collect specimens, return them via prepaid shipping, and receive results through a secure Clinician Portal.

Is US BioTek Laboratories a public or private company?

US BioTek Laboratories is a private company. It is classified as private equity controlled and is currently operating.

When was US BioTek Laboratories founded?

US BioTek Laboratories was founded in 1998. It employs 51 to 100 people.

Where is US BioTek Laboratories based?

US BioTek Laboratories is headquartered in Shoreline, United States, in the North America region.

How does US BioTek Laboratories make money?

One revenue line is on record: clinical Laboratory Testing Services.

Who are US BioTek Laboratories's main competitors?

Direct peers on record are Genova Diagnostics, Doctor's Data, Mosaic Diagnostics (formerly Great Plains Laboratory), ZRT Laboratory, Diagnos-Techs, Meridian Valley Lab and NutriPATH Pathology. Broad incumbents are Quest Diagnostics, Labcorp and Sonic Healthcare.

Does US BioTek Laboratories have an API?

No public API is recorded for US BioTek Laboratories.

What industry is US BioTek Laboratories in?

US BioTek Laboratories's product category is Clinical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAB, Clinical Chemistry & Immunoassay Laboratories, with a secondary code of HLAGADAN, Food, Feed & Nutraceutical Analytical Testing. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0US BioTek Laboratories Completes Merger With Australian Pathology Provider NutriPATHUS BioTek Laboratories, a Seattle-based functional laboratory specializing in immunological and integrative diagnostics, has completed its merger with Australian functional pathology provider NutriPATH Pathology. The transaction combines two organizations focused on clinical relevance and scientific rigor in the functional medicine space, with the combined entity aiming to broaden international access to comprehensive, clinically actionable testing solutions. NutriPATH will continue operating under its established brand in Australia while gaining access to additional resources and collaborative scientific development capabilities through the merged organization.PR NewswireUS BioTek Laboratories Completes Merger With NutriPATH PathologyUS BioTek Laboratories, a functional laboratory specializing in immunological and integrative diagnostics, has completed its merger with NutriPATH Pathology, a functional pathology laboratory serving integrative medicine practitioners. The combination brings together US BioTek's expertise in immune reactivity, food sensitivity, and specialty biomarker testing with NutriPATH's functional pathology, nutritional assessment, and gut health diagnostics capabilities, expanding both companies' international footprint. NutriPATH will continue operating under its established brand in Australia while gaining access to expanded resources, technologies, and collaborative scientific development.UsbiotekUS BioTek Laboratories Merges with NutriPATH PathologyUS BioTek Laboratories has completed its merger with NutriPATH Pathology, combining two functional pathology laboratories serving integrative and functional medicine practitioners. The merger integrates US BioTek's expertise in immune reactivity, food sensitivity, and specialty biomarker testing with NutriPATH's functional pathology, nutritional assessment, and gut health diagnostics capabilities. The combined organization will operate under both established brands, with NutriPATH maintaining its presence in Australia while gaining access to expanded resources and collaborative scientific development.MorningstarUS BioTek Laboratories Completes Merger With NutriPATH PathologyUS BioTek Laboratories has completed its merger with NutriPATH Pathology, combining US BioTek's expertise in immunological and specialty biomarker testing with NutriPATH's functional pathology and gut health diagnostics capabilities. The merged entity, spanning Seattle and Melbourne, will offer an expanded portfolio of testing solutions to integrative and functional medicine practitioners worldwide. Both organizations have committed to a seamless transition while maintaining their respective brand presences.Private Equity InsightsPike Street Closes $237 million Inaugural Fund Targeting Industrial Technology – Private Equity InsightsSeattle-based private-equity firm Pike Street Capital has closed its inaugural fund at $237 million, exceeding its original $200 million target, with plans to invest in industrial technology companies across testing and measurement, specialty manufacturing, and distribution/logistics sectors. The firm has already deployed capital into three portfolio companies: US BioTek Laboratories, QuickBox Fulfillment, and Trublue LLC (Head Rush Technologies), with US BioTek notably pivoting to antibody and virus testing during the COVID-19 pandemic. Founded in 2018 by Paul Caragher, David Dandel, and Edward Whatley, Pike Street targets controlling stakes in companies with $10 million to $100 million in revenue.PR NewswireUS BioTek Laboratories Expands Diagnostic Testing Portfolio with Acquisition of RealTime LaboratoriesUS BioTek Laboratories acquired Dallas-based RealTime Laboratories, a mycotoxin testing specialist, to expand its diagnostic portfolio. The deal adds RealTime's technology and expertise, with both labs continuing operations in Seattle and Dallas. The acquisition aims to accelerate new test development and broaden customer access.PR NewswireUS BioTek Laboratories Launches At-Home STI Testing for PrEPUS BioTek Laboratories announced on May 17, 2023 the launch of at-home self-collected STI testing panels, including options specifically designed for PrEP users. The new testing options aim to address barriers to testing such as patient hesitancy and limited access to healthcare facilities, with results guaranteed within 36 hours of sample receipt. The panels are available to all practitioners with US BioTek accounts, expanding the company's existing laboratory testing services into the home collection market.PR NewswireUS BioTek Laboratories Launches MycoToxin TestingUS BioTek Laboratories announced the launch of mycotoxin testing on March 22, 2023, offering patients insights into their toxic burden from mold exposure. The new MycoToxin Profile evaluates 16 of the most common pathogenic mycotoxins produced by over 100 different mold species, with an expanded MOE-Tox Complete Profile combining environmental pollutants and organic acids testing. The testing service is now available to practitioners with US BioTek accounts.PR NewswireUS BioTek Laboratories Launches Monkeypox Diagnostic TestingUS BioTek Laboratories announced on October 13, 2022, that it is now offering Monkeypox Diagnostic Testing using real-time RT-PCR technology with results delivered within 24 hours of receiving specimens. The test uses a skin lesion swab collection method and is available to all practitioners with US BioTek accounts, as part of the company's effort to help stop the spread of the Monkeypox virus. The company's CEO emphasized the importance of quickly knowing viral status for personal and public health.